Alberto
Mocchi

Counsel
All we have to decide is what to do with the time that is given us. Gandalf – The Lord of the ring. JRR Tolkien

Alberto specializes in commercial, corporate, pharmaceutical and regulatory fields. In particular, he assists companies operating in the Life Sciences sector in all stages of drug life, both in judicial and non-litigation activities.
He also provides support in the drafting of commercial agreements (i.e., manufacturing, licensing, supply, and distribution) and legal opinions on compliance and privacy matters.
He has extensive knowledge of business processes and clients’ needs obtained during outsourcing programs for pharmaceutical clients.
He is a member of Supervisory Bodies pursuant to Italian Legislative Decree 231/2001.

Alberto joined LCA in January, 2021.
He has gained almost 20 years of experience at Franzosi Dal Negro Setti Law Firm in Milan where he was a partner from 2015 to 2020.

  • Legal 500 2026

    Recommended Lawyer for Healthcare and Life Sciences

  • Leaders League 2026

    Excellent for Health & Pharmaceutical Industry

Commercial and corporate IT & Data Protection Manufacturing Life Sciences

You might also be interested in

09.10.2026
LCA advises the selling shareholders on the sale of Planta to SIS

The transaction strengthens the maize genetics platform of the BF group’s seed division

05.10.2026
LCA alongside Impresoft in the acquisition of Marketplace Generation and Addiction ...

The group controlled by Clessidra Private Equity strengthens its e-commerce and MarTech offering  

01.10.2026
LCA Studio Legale strengthens the Corporate M&A practice with the arrival of ...

The firm consolidates the practice in extraordinary transactions and in advising Italian and U.S. investors  

25.09.2026
LCA advises the sellers on the sale of 60% of Ecupharma to Adamed Group

Majority stake sold in the Italian pharmaceutical company active in neurology, psychiatry, urology and diabetology

21.09.2026